A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms
Abstract
1. Introduction
2. Case Presentation
3. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Yuan, X.; Huang, W.; Ye, B.; Chen, C.; Huang, R.; Wu, F.; Wei, Q.; Zhang, W.; Hu, J. Changes of hematological and immunological parameters in COVID-19 patients. Int. J. Hematol. 2020, 112, 553–559. [Google Scholar] [CrossRef] [PubMed]
- Lippi, G.; Henry, B.M. Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19). Respir. Med. 2020, 167, 105941. [Google Scholar] [CrossRef] [PubMed]
- COVID-19–Associated Multisystem Inflammatory Syndrome in Children—United States, March–July 2020 Weekly/August 14, 2020/69(32);1074–1080. Available online: https://www.cdc.gov/mis-c/hcp (accessed on 14 August 2020).
- Hoang, A.; Chorath, K.; Moreira, A.; Evans, M.; Burmeister-Morton, F.; Burmeister, F.; Naqvi, R.; Petershack, M.; Moreira, A. COVID-19 in 7780 pediatric patients: A systematic review. EClinicalMedicine 2020, 24, 100433. [Google Scholar] [CrossRef]
- Feldstein, L.R.; Rose, E.B.; Horwitz, S.M.; Collins, J.P.; Newhams, M.M.; Son, M.B.F.; Newburger, J.W.; Kleinman, L.C.; Heidemann, S.M.; Martin, A.A.; et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020, 383, 334–346. [Google Scholar] [CrossRef] [PubMed]
- Dufort, E.M.; Koumans, E.H.; Chow, E.J.; Rosenthal, E.M.; Muse, A.; Rowlands, J.; Barranco, M.A.; Maxted, A.M.; Rosenberg, E.S.; Easton, D.; et al. Multisystem Inflammatory Syndrome in Children in New York State. N. Engl. J. Med. 2020, 383, 347–358. [Google Scholar] [CrossRef]
- Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020, 395, 507–513. [Google Scholar] [CrossRef]
- Bomhof, G.; Mutsaers, P.G.N.J.; Leebeek, F.W.G.; Boekhorst, P.A.W.T.; Hofland, J.; Croles, F.N.; Jansen, A.J.G. COVID-19-associated immune thrombocytopenia. Br. J. Haematol. 2020, 190, e61–e64. [Google Scholar] [CrossRef]
- Słomka, A.; Kowalewski, M.; Żekanowska, E. Coronavirus Disease 2019 (COVID–19): A Short Review on Hematological Manifestations. Pathogenes 2020, 9, 493. [Google Scholar] [CrossRef] [PubMed]
- Rahman, A.; Niloofa, R.; Jayarajah, U.; De Mel, S.; Abeysuriya, V.; Seneviratne, S.L. Hematological Abnormalities in COVID-19: A Narrative Review. Am. J. Trop. Med. Hyg. 2021, 104, 1188–1201. [Google Scholar] [CrossRef]
- Bhattacharjee, S.; Banerjee, M. Immune Thrombocytopenia Secondary to COVID-19: A Systematic Review. SN Compr. Clin. Med. 2020, 2, 2048–2058. [Google Scholar] [CrossRef]
- Thompson, S.; Bohnm, M.K.; Mancini, N.; Loh, T.P.; Wang, C.B.; Grimmler, M.; Yuen, K.-Y.; Mueller, R.; Koch, D.; Sethi, S.; et al. IFCC Interim Guidelines on Biochemical/ Hematological Monitoring of COVID-19 Patients. Clin. Chem. Lab. Med. 2020, 58, 2009–2016. [Google Scholar] [CrossRef] [PubMed]
- Margekar, S.L.; Margekar, P.; Kumar, A.; Margekar, V.G. Hematological profile in COVID-19, whether it matters in children. Indian J. Med. Spec. 2021, 12, 11. [Google Scholar] [CrossRef]
- Xiong, X.; Chua, G.T.; Chi, S.; Kwan, M.Y.; Wong, W.H.; Zhou, A.; Shekd, C.C.; Tung, K.T.S.; Qin, H.; Wong, R.S.; et al. Haematological and immunological data of Chinese children affected with coronavirus disease 2019. Data Brief 2020, 31, 105953. [Google Scholar] [CrossRef]
- Tsao, H.S.; Chason, H.M.; Fearon, D.M. Immune Thrombocytopenia (ITP) in a Pediatric Patient Positive for SARS-CoV-2. Pediatrics 2020, 146, e20201419. [Google Scholar] [CrossRef] [PubMed]
- Patel, P.; Chandrakasan, S.; Mickells, G.E.; Yildirim, I.; Kao, C.M.; Bennett, C.M. Severe Pediatric COVID-19 Presenting with Respiratory Failure and Severe Thrombocytopenia. Pediatrics 2020, 146, e20201437. [Google Scholar] [CrossRef] [PubMed]
- Rosenzweig, J.D.; McThenia, S.S.; Kaicker, S. SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the pandemic. Pediatr. Blood Cancer 2020, 67, e28503. [Google Scholar] [CrossRef]
- Han, Y.N.; Feng, Z.W.; Sun, L.N.; Ren, X.X.; Wang, H.; Xue, Y.M.; Wang, Y.; Fang, Y. A comparative—Descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults. J. Med. Virol. 2020, 92, 1596–1602. [Google Scholar] [CrossRef]
- Yang, M.; Ng, M.H.; Li, C.K. Thrombocytopenia in patients with severe acute respiratory syndrome (review). Hematology 2005, 10, 101–105. [Google Scholar] [CrossRef]
- Xu, P.; Zhou, Q.; Xu, J. Mechanism of thrombocytopenia in COVID-19 patients. Ann. Hematol. 2020, 99, 1205–1208. [Google Scholar] [CrossRef] [PubMed]
- Mehta, P.; McAuley, D.F.; Brown, M.; Sanchez, E.; Tattersall, R.S.; Manson, J.J. COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020, 395, 1033–1034. [Google Scholar] [CrossRef]
- Yamada, T.; Wakabayashi, M.; Yamaji, T.; Chopra, N.; Mikami, T.; Miyashita, H.; Miyashita, S. Value of leukocytosis and elevated C-reactive protein in predicting severe coronavirus 2019 (COVID-19): A systematic review and meta-analysis. Clin. Chim. Acta 2020, 509, 235–243. [Google Scholar] [CrossRef] [PubMed]
- Zhang, S.; Li, L.; Shen, A.; Chen, Y.; Qi, Z. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia. Clin. Drug Investig. 2020, 40, 511–518. [Google Scholar] [CrossRef] [PubMed]
- Yarali, N.; Akcabelen, Y.M.; Unal, Y.; Parlakay, A.N. Hematological parameters and peripheral blood morphologic abnormalities in children with COVID-19. Pediatr. Blood Cancer 2020, e28596. [Google Scholar] [CrossRef]
- Hashemieh, M. Hematologic parameters of COVID—19: A review on alteration of hematologic laboratory findings. Int. J. Pediatr. 2020, 8, 11321–11929. [Google Scholar]
- Chen, X.; Ling, J.; Mo, P.; Zhang, Y.; Jiang, Q.; Ma, Z.; Cao, Q.; Hu, W.; Zou, S.; Chen, L.; et al. Restoration of leukomonocyte counts is associated with viral clearance in COVID-19 hospitalized patients. Medrxiv 2020. [Google Scholar] [CrossRef]
- Lu, X.; Zhang, L.; Du, H.; Zhang, J.; Li, Y.Y.; Qu, J.; Zhang, W.; Wang, Y.; Bao, S.; Li, Y.; et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 2020, 382, 1663–1665. [Google Scholar] [CrossRef] [PubMed]
- Henry, B.M.; Lippi, G.; Plebani, M. Laboratory abnormalities in children with novel coronavirus disease 2019. Clin. Chem. Lab. Med. 2020, 58, 1135–1138. [Google Scholar] [CrossRef]
- Qiu, H.; Wu, J.; Hong, L.; Luo, Y.; Song, Q.; Chen, D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect. Dis. 2020, 20, 689–696. [Google Scholar] [CrossRef]
- Ma, H.; Hu, J.; Tian, J.; Zhou, X.; Li, H.; Laws, M.T.; Wesemann, L.D.; Zhu, B.; Chen, W.; Ramos, R.; et al. Visualizing the Novel Coronavirus (COVID-19) in Children: What we Learn from Patients at Wuhan Children’s Hospital. 2020. Available online: https://ssrn.com/abstract=3550012 (accessed on 16 March 2020). [CrossRef]
- Sun, D.; Li, H.; Lu, X.-X.; Xiao, H.; Ren, J.; Zhang, F.-R.; Liu, Z.-S. Clinical features of severe pediatric patients with coronavirus disease 2019 in Wuhan: A single center’s observational study. World J. Pediatr. 2020, 16, 251–259. [Google Scholar] [CrossRef] [PubMed]
- Kosmeri, C.; Koumpis, E.; Tsabouri, S.; Siomou, E.; Makis, A. Hematological manifestations of SARS-CoV-2 in children. Pediatr. Blood Cancer 2020, 67, e28745. [Google Scholar] [CrossRef] [PubMed]
- Liu, J.; Liu, Y.; Xiang, P.; Pu, L.; Xiong, H.; Li, C.; Zhang, M.; Tan, J.; Xu, Y.; Song, R.; et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J. Transl. Med. 2020, 18, 206. [Google Scholar] [CrossRef] [PubMed]
- Meena, J.; Yadav, J.; Saini, L.; Yadav, A.; Kumar, J. Clinical Features and Outcome of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-analysis. Indian Pediatr. 2020, 57, 820–826. [Google Scholar] [CrossRef] [PubMed]
- Tiwari, N.; Nath, D.; Madan, J.; Bajpai, P.; Madan, U.; Singh, S. Novel Insights into the Hematological Parameter Abnormalities in Pediatric COVID-19 Cases: Observation from A Preliminary Study of 11 Pediatric COVID-19 Cases in A Tertiary Care Center of North India. SJPM 2020, 5, 276–284. [Google Scholar] [CrossRef]
- Lippi, G.; Mattiuzzi, C. Hemoglobin value may be decreased in patients with severe coronavirus disease 2019. Hematol. Transfus. Cell Ther. 2020, 42, 116–117. [Google Scholar] [CrossRef] [PubMed]
- Liu, W.; Li, H. COVID-19: Attacks the 1-beta chain of hemo- globin and captures the porphyrin to inhibit human heme metabolism. ChemRxiv 2020. [Google Scholar] [CrossRef]
Immunoglobulings | Normal Values (mg/dL) |
IgG | 1150 (863–1847) |
IgA | 128 (70–400) |
IgM | 100 (40–289) |
C3 | 116 (90–180) |
C4 | 16 (13–75) |
Virology panel: | |
Human Herpes Virus 6 (HHV6) | IgM(-), IgG(-) |
Mycoplasma pneumoniae | IgM(-), IgG(-) |
Herpes Simplex 1,2 (HSV1,2) | IgM(-), IgG(-) |
Adenovirus | IgM(-), IgG(+) |
Parvo B19 | IgM(-), IgG(-) |
Anti HBsAg | (-) |
Anti-HBs | (+) |
Anti-HCV | (-) |
Human Immunodeficiency virus (HIV) | (-) |
Toxoplasma gondii | IgM(-), IgG(-) |
Cytomegalovirus (CMV) | IgM(-), IgG(-) |
Epstein -Barr virus (EBV) | IgM(-), IgG(+) |
SARs-COV-2 (PCR) | negative |
SARs-COV-2 abs * IgA IgG IgM | POSITIVE 2.48 (negative < 0.8) 1.32 (negative < 0.8) 1.34 (negative < 0.28) |
Ferritin | 32.7 ng/ml (4.6–274) |
B12 | 652 pg/ml (187–883) |
TSH | 1.27 mIU/ml (0.35–4.94) |
Bleeding screening panel: (PT, aPTT, INR, Fibrinogen, D-dimers) | normal |
Direct anti-globulin test: negative | negative |
Immunophenotype of lymphocyte subpopulation of peripheral blood: | (CD3+) 72.1% (CD4+) 40.5% (CD8+)31.8% |
Laboratory Tests | Admission to the Adolescent Health Unit | Admission to the Adolescent Health Unit | 3 Months Later (Five Months from the Initial FBC) |
---|---|---|---|
WBC (/μL) | 3.400 | 3900 | 4100 |
PMN:45.3% (absolute number: 1533) LYM: 47.7% (absolute number: 1621) MONO: 4.9% | PMN: 44% (absolute number: 1716) LYM: 46%, (absolute number: 1794) MONO: 6% | PMN: 39.3% (absolute number: 1600) LYM: 53.1%, (absolute number: 2200) MONO: 5.4% | |
Hb (g/dL) | 12.3 | 11.6 | 12.1 |
MCV (fL) | 64 | 65.2 | 67.3 |
PLT(/μL) | 86,000—platelet anisocytosis | 130,000 | 112,000 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kossiva, L.; Thirios, A.; Panagouli, E.; Panos, A.; Lampidi, S.; Bacopoulou, F.; Tsolia, M.; Tsitsika, A. A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms. Children 2021, 8, 509. https://doi.org/10.3390/children8060509
Kossiva L, Thirios A, Panagouli E, Panos A, Lampidi S, Bacopoulou F, Tsolia M, Tsitsika A. A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms. Children. 2021; 8(6):509. https://doi.org/10.3390/children8060509
Chicago/Turabian StyleKossiva, Lydia, Athanasios Thirios, Eleni Panagouli, Alexandros Panos, Stavroula Lampidi, Flora Bacopoulou, Maria Tsolia, and Artemis Tsitsika. 2021. "A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms" Children 8, no. 6: 509. https://doi.org/10.3390/children8060509
APA StyleKossiva, L., Thirios, A., Panagouli, E., Panos, A., Lampidi, S., Bacopoulou, F., Tsolia, M., & Tsitsika, A. (2021). A Case of COVID-19-Related Thrombocytopenia and Leukopenia in an Adolescent with Mild Symptoms. Children, 8(6), 509. https://doi.org/10.3390/children8060509